News & Events - Inventiva Pharma

News & Events

Shareholders Meeting of April 16, 2021 – Availability of the preparatory documents and methods for participating and voting

Inventiva announces filing of its 2020 Universal Registration Document and 2020 Annual Report on Form 20-F

2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States

Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvement

25 February 2021

Inventiva to participate at several investor conferences in March 2021

24 February 2021

Inventiva’s 2020 Full-Year Financial Results Presentation

23 February 2021

Full-Year 2020: Cash position and revenues

11 February 2021

Inventiva to present at the 39th Annual J.P. Morgan Healthcare Conference

Inventiva announces design of Phase III clinical trial with lanifibranor in NASH

Load More

Upcoming Investors Meetings

Upcoming Science Conferences

Questions?
Get in touch!

Inventiva
Frédéric Cren
Chief Executive Officer
info@inventivapharma.com
+33 3 80 44 75 00

Brunswick
Yannick Tetzlaff / Tristan Roquet Montegon / Aude Lepreux
Media relations
inventiva@brunswickgroup.com
+33 1 53 96 83 83

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com